Weekly Skin Scan

Welcome to The Weekly Skin Scan where our editors keep you up-to-date on the latest news and research that could impact your practice. Browse more stories here.

Covid-19 Update

Teledermatology and HIPAA compliance in the era of COVID-19

David J. Goldberg, M.D., J.D., discusses important considerations regarding telemedicine and HIPAA compliance that dermatologists should keep in mind during the COVID-19 pandemic.

Plans for reopening the private practice

From the Aesthetic Authority
Dr. Mike Nayak talks issues of safety and practicality regarding national reopening guidelines, and the benefits of collaborating with local multi-specialty practices to share ideas and determine best practices together.

Acne and Rosacea

Menlo, Cutia enter agreement for topical minocycline products

Menlo Therapeutics announces its wholly-owned subsidiary Foamix Pharmaceuticals Ltd. is entering a licensing with Cutia Therapeutics for the company’s FDA-approved 4% topical minocycline foam (AMZEEQ, Foamix) for acne vulgaris in pediatric and adult patients.

Novel topical foam promising for papulopustular rosacea

Published results from two 12-week, vehicle-controlled phase 3 studies show that a novel topical foam formulation of minocycline 1.5% may be effective in reducing inflammatory lesions.

Psoriasis and Atopic Dermatitis

Patient enrollment completed for Dermavant phase 3 psoriasis clinical trials

Dermavant announces the enrollment completion for their two phase 3 clinical trials investigating the topical therapeutic aryl hydrocarbon receptor (TAMA) tapinarof as a treatment for adult plaque psoriasis, with results from the study still expected in the second half of 2020 despite the current pandemic.

LEO Pharma enters agreement to develop novel drug for atopic dermatitis, asthma

LEO Pharma has entered into a license agreement with Oneness Biotech and Microbio Shanghai for the development and commercialization of the investigational drug FB825 for the treatment of atopic dermatitis and asthma.

Connect with us on Twitter and Facebook for daily updates.

From our Latest Issue

Targeted therapies for advanced basal cell carcinoma

Abrocitinib works quickly in atopic dermatitis

Guidance on transitioning psoriasis patients between biologics